iCAD to Participate in Upcoming Virtual Investor Conferences

NASHUA, N.H.,
May 17, 2021 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology
leader providing innovative cancer detection and therapy solutions, today
announced that Michael Klein, iCAD’s Chairman and Chief Executive Officer, will
be participating at the following three virtual investor conferences in May and
June:

• Oppenheimer’s
  MedTech, Tools & Diagnostics Summit will post a pre-recorded
  presentation on Wednesday, May 26, 2021.
• The
  2021 Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 will
  host a live presentation starting at 3:00 p.m. ET.
• 18th
  Annual Craig-Hallum Institutional Investor Conference will host virtual
  1×1 meetings on June 2, 2021.

Webcasts of
all events will be available in the Investor Relations section of the
Company’s website, https://www.icadmed.com/financial-news-and-events.html. An
audio archive of all the presentations will also be available on the website.

About
iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader
providing innovative cancer detection and therapy solutions. For more
information, visit www.icadmed.com.

Contact:

Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com

Investor
Relations:
Jeremy Feffer, LifeSci Advisors
+ 1-212-915-2568
jeremy@lifesciadvisors.com